drug development - International Pharmaceutical Industry

News

Glox Therapeutics Awarded Grant to Accelerate Development of Precision Antibiotics

Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has announced it has secured £1 ...

27 November 2024 News antibiotics | development

Continue Reading →

Volume 16 Issue 2

Advances in Intranasal Vaccine Delivery: A Promising Non-Invasive Route of Immunisation

Vaccination is an effective weapon for disease prevention and has been proven to significantly reduce the transmission of infections and the number of deaths worldwi...

8 July 2024 Volume 16 Issue 2 | Editorial Archive development | drug development

Continue Reading →

News

Love Pharma moves to buy transdermal opioid-use disorder player

Love Pharma has struck a deal to acquire transdermal drug delivery technology, signing a letter of intent to buy Naltrexone Therapeutics for intellectual property co...

19 October 2022 News Biopharma | biopharmaceutical

Continue Reading →

News

Bankrupt Zosano sells intradermal delivery tech to Emergex Vaccines

The unraveling of Zosano Pharma has led to a drug delivery deal. With the company filing for bankruptcy in the wake of its rejection by the FDA, Emergex Vaccines has...

19 October 2022 News biopharmaceutical | biopharmaceutical industries

Continue Reading →

Volume 13 Issue 4

Hyper-collaboration in Healthcare and Life Sciences – The New Paradigm

The COVID-19 pandemic demonstrated the ability of the healthcare and life science industry to respond to unexpected needs with unprecedented speed. However, independ...

24 November 2021 Volume 13 Issue 4 COVID-19 vaccine | drug development

Continue Reading →

Volume 13 Issue 4

The Brave New World of Rapid Drug Development

The COVID-19 pandemic has brought the topic of rapid drug development to the forefront of the life sciences sector. Ray Chohan at PatSnap, believes that we have ente...

24 November 2021 Volume 13 Issue 4 COVID-19 | drug development

Continue Reading →

News

AiPharma forms alliance with Appili Therapeutics

Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Th...

6 October 2021 News AiPharma | Appili Therapeutics

Continue Reading →

Volume 13 Issue 3

Biotech in China: Maximising the Global Opportunity

Pharmaceutical companies from China are showing an increasing interest in international market opportunities, focusing on new drug developments in the biological fie...

13 September 2021 Volume 13 Issue 3 biological | biotech

Continue Reading →

Volume 13 Issue 3

The Case for a Distributable CDx Model

The past decade has been an exciting era in healthcare for patients and providers with the increasingly broad adoption of precision medicine in drug development, cli...

13 September 2021 Volume 13 Issue 3 clinical trials | drug development

Continue Reading →

News

Syneos Health and Aetion partner to offer real-world evidence solutions

Syneos Health and Aetion have announced a partnership to provide regulatory-grade data and analytics-driven solutions to advance drug development and improve pa...

3 August 2021 News Aetion | drug development

Continue Reading →